4
Changes in Ownership
Werewolf Therapeutics, Inc. Filed Acc 0000899243-23-001409
Options or other derivatives
- Chief Scientific Officer acquired 115,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Seidel-Dugan Cynthia Chief Scientific Officer | 2023-01-03 | Grant or award · Stock Option (right to buy) | +115,900 | 115,900 | D | ||
Loading xslF345X03/doc4.xml…